Early infections in patients undergoing bone marrow or blood stem cell transplantation - A 7 year single centre investigation of 409 cases

Bone Marrow Transplantation

Volumn 23, Issue 6, 1999, Pages 589-597

  Kruger W ^a   Russmann B ^a   Kroger N ^a   Salomon, C ^a   Ekopf, N ^a   Elsner, H A ^a   Kaulfers, P M ^a   Mack, D ^a   Fuchs, N ^a   Durken M ^a   Kabisch, H ^a   Erttmann, R ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Allogeneic; Bacteria; Blood stem cell transplantation; High dose therapy; Infection; Marrow transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIINFECTIVE AGENT; FLUCONAZOLE; GROWTH FACTOR; PENTAMIDINE; QUINOLONE; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ANTIMICROBIAL THERAPY; ARTICLE; ASPERGILLUS; AUTOGRAFT; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANDIDA; CHILD; FEMALE; GRAM POSITIVE BACTERIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SEPTICEMIA;

EID: 0344142342     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701614     Document Type: Article

References (27)

1. Kolbe K, Domkin D, Derigs HG et al. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143-147.
2. Nosanchuk JD, Sepkowitz KA, Pearse RN et al. Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 1996; 18: 355-359.
3. Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986; 81: 27-38.
4. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia (see comments). New Engl J Med 1993; 328: 1323-1332.
5. Krüger W, Sobottka I, Stockschläder M et al. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin B. A report of 4 cases with determination of the Mic values. Scand J Infect Dis 1996; 28: 313-316.
6. Reed EC. Infectious complications during autotransplantation. Hematol Oncol Clin North Am 1993; 7: 717-735.
7. Zander AR, Reuben JM, Johnston D et al. Immune recovery following allogeneic bone marrow transplantation. Transplantation 1985; 40: 177-183.
8. Tollemar J, Ringden O, Bostrom L et al. Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 635-641.
9. Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265-271.
10. Wingard JR, Beals SU, Santos GW et al. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant 1987; 2: 175-181.
11. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17 (Suppl. 6): 10-13.
12. Russell JA, Poon MC, Jones AR et al. Allogeneic bone-marrow transplantation without protective isolation in adults with malignant disease. Lancet 1992; 339: 38-40.
13. Bacigalupo A, Tedone E, Sanna MA et al. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality. Haematologica 1992; 77: 507-513.
14. Almeida-Porada GD, Ascensao JL. Cytomegalovirus as a cause of pancytopenia. Leuk Lymphoma 1996; 21: 217-223.
15. Preiksaitis JK, Janowska-Wieczorek A. Persistence of cytomegalovirus in human long-term bone marrow culture: relationship to hemopoiesis. J Med Virol 1991; 35: 76-84.
16. Kay HE, Watson JG, Jameson B et al. Infections after bone marrow transplantation using cyclosporine. Transplantation 1983; 36: 491-495.
17. Meyers JD, Bowden RA, Counts GW. Infectious complications of marrow transplant: risk factors for infection. Prog Clin Biol Res 1989; 309: 357-366.
18. Maschmeyer G, Vogt K, Hahn H, Dorken B. Antimicrobial therapy in neutropenia. Dtsch Med Wochenschr 1997; 122: 864-869.
19. Nosari A, Barberis M, Landonio G. Infections in haematologic noplasms: autopsy findings. Haematologica 1991; 76: 135-140.
20. Dekker AW, Verdonck LF, Rozenberg-Arska M. Infection prevention in autologous bone marrow transplantation and the role of protective isolation. Bone Marrow Transplant 1994; 14: 89-93.
21. Winston DJ, Gale RP, Meyer DV, Young LS. Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 1979; 58: 1-31.
22. Krüger W, Stockschläder M, Rüssmann B et al. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation. Br J Haematol 1995; 91: 684-690.
23. Prentice HG, Hann IM, Herbrecht R et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 1997; 98: 711-718.
24. Castagnola E, Bucci B, Montinaro E, Viscoli C. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol. Bone Marrow Transplant 1996; 18 (Suppl. 2): 97-106.
25. Ehninger G, Schuler HK, Sarnow E. Fluconazole in the prophylaxis of fungal infection after bone marrow transplantation. Mycoses 1996; 39: 259-263.
26. Lam HH, Althaus BL. Antifungal prophylaxis in bone marrow transplant. Ann Pharmacother 1995; 29: 921-924.
27. Gluckman E, Roudet C, Hirsch I et al. Prophylaxis of bacterial infections after bone marrow transplantation. A randomized prospective study comparing oral broad-spectrum nonabsorbable antibiotics (vancomycin-tobramycin-colistin) to absorbable antibiotics (ofloxacin-amoxicillin). Chemotherapy 1991; 37 (Suppl. 1): 33-38.